Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium benzoate for treatment-resistant schizophrenia
jRCTs031200050Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sodium benzoate in schizophrenia and schizoaffective disorder, sponsored by Japan Society for the Promotion of Science. Primary endpoint: Primary: Change in brain glutamate and glutathione levels. Started Jun 2020; status: completed.
02
Drugs
sodium benzoate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on jRCTs031200050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200050.